By Brian Amaral ( August 17, 2016, 5:52 PM EDT) -- A Massachusetts federal judge on Wednesday invalidated Janssen Biotech Inc.'s patent for the drug Remicade, handing a significant but not decisive victory to Celltrion Healthcare Co. Ltd. and Hospira Inc., which are looking to launch biosimilar versions of the $4 billion immunosuppressant drug in the United States this year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.